Clinical Trials Browser

Phase 2 × Solid Tumor × envafolimab × Clear all

NCT04891198 2026-03-25

ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor